| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241258A VEGF-8/receptor complex and uses thereof |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/12/2000 | CN1241133A Extracellular matrix production promoter |
| 01/12/2000 | CN1240830A High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus |
| 01/12/2000 | CN1240792A Medicine combined by moleculae of growth factor and traumatic factor in gall |
| 01/12/2000 | CN1048157C Compouded injection of ribonucleic acid and heparin |
| 01/11/2000 | US6013788 Antisense modulation of Smad3 expression |
| 01/11/2000 | US6013787 Antisense modulation of Smad4 expression |
| 01/11/2000 | US6013786 Nucleotide sequences used as inhibitors of the oncogenic action of the encoded protein; antitumor agents |
| 01/11/2000 | US6013785 Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages |
| 01/11/2000 | US6013784 Nucleic acids encoding HST 2 muteins |
| 01/11/2000 | US6013782 Integrin-linked kinase and its uses |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013780 VEGF145 expression vectors |
| 01/11/2000 | US6013773 Pharmaceutical preparation containing human growth hormone |
| 01/11/2000 | US6013772 Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays |
| 01/11/2000 | US6013769 X-linked adrenoleukodystrophy gene and corresponding protein |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013764 Liquid phase peptide synthesis of KL-4 pulmonary surfactant |
| 01/11/2000 | US6013762 Recombinant non-glycosylated beta tumor cell growth factor; for the diagnosis and treatment of diabetic vision defects, atherosclerosis, and ulcers; wound healing agents; antiproliferative agents |
| 01/11/2000 | US6013680 The medicine comprises a combination of at least one agent selected from the group consisting of histamine h2 receptor antagonists and proton pump inhibitors, and a digestive enzyme to treat gastric ulcer |
| 01/11/2000 | US6013678 Administering to a patient suffering from congestive heart failure a therapeutically effective amount of 5,6-diisobutyroyloxy-2-methylaminotetralin or a salt |
| 01/11/2000 | US6013659 Methods of reducing tumor colony number using novel benzothiazole compounds |
| 01/11/2000 | US6013658 Animal growth regulators |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013645 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/11/2000 | US6013639 G cap-stabilized oligonucleotides |
| 01/11/2000 | US6013633 Administering dipeptides and tripeptides |
| 01/11/2000 | US6013632 Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or n-acetyl-l-cysteine, with or without antioxidants |
| 01/11/2000 | US6013631 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 01/11/2000 | US6013630 Using mutant atrial natriuretic factor proteins, fragments, analogs, derivatives and homologs thereof, the nucleic acids encoding these mutant proteins, and modulators of atrial natriuretic factor for treating or preventing ischemic stroke |
| 01/11/2000 | US6013629 Anti-protozoan methods and materials |
| 01/11/2000 | US6013628 Treating proliferative vitreoretinopathy and glaucoma by administering polypeptide which includes sequence of at least 5 amino acids corresponding to an amino acid sequence from within the 33 kd fragment of the a chain of fibronectin |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013626 To inhibit the proliferation of mammalian cells; antitumor agents |
| 01/11/2000 | US6013625 Method and composition for treating thrombosis |
| 01/11/2000 | US6013624 Administering an amount of scatter factor effective to induce the proliferation and migration of endothelial cells in the subject; wound healing |
| 01/11/2000 | US6013623 Use of heme-peptides to prevent or retard disease associated with oxidative stress |
| 01/11/2000 | US6013620 Contacting factor vii-containing fraction with anion exchanger, wherein factor vii is partially activated, isolating fraction containing activated factor vii, wherein fraction has factor viii inhibitor bypassing activity |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013526 Modified protein for gene transfer and process for producing the same |
| 01/11/2000 | US6013522 Oligonucleotides 8 to 30 nucleotides in length targeted to a untranslated region of a nucleic acid sequence; anticarcinogenic agents |
| 01/11/2000 | US6013515 Cofactors for HIV-1 protein Tat and methods of use therefor |
| 01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
| 01/11/2000 | US6013499 Rho target protein kinase p160 |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013495 Methods of use for integrin B1C cell growth inhibitor |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013481 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 01/11/2000 | US6013480 Antagonists of interleukin-15 |
| 01/11/2000 | US6013479 Human Emr1-like G protein coupled receptor |
| 01/11/2000 | US6013478 Producing modified human polypeptides in cells; culturing cell transformed with a replicable expression vector containing modified nucleotide and amino acid sequences, recovering the expressed product polypeptide |
| 01/11/2000 | US6013477 Polypeptide molecule with cellular growth activity; for detecting mutations in the coding sequence of the polypeptide; wound healing agents; antiproliferative agents |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013475 Nucleotide sequences coding a protein that binds to a receptor/ligand complex; for treatment of autoimmune diseases, graft rejection, and cancer |
| 01/11/2000 | US6013473 Nucleic acid sequence encoding a deoxyribonucleic acid repair enzyme; for treatment, prevention, and diagnosing cancer; antitumor/anticarcinogenic agents |
| 01/11/2000 | US6013471 DNA encoding hK2 variant polypeptides |
| 01/11/2000 | US6013470 Family of mammalian potassium channels, their cloning and their use especially for the screening of drugs |
| 01/11/2000 | US6013464 Human PAK65 |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013462 Purifying or analyzing a human glutathione-s-transferase from a sample by contacting with a solid support coupled to tripeptide analog, and allowing enzyme to adsorb to support |
| 01/11/2000 | US6013458 Conformationally constrained compounds which mimic the secondary structure of biologically active peptides and proteins; for screening libraries |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013453 Libraries of dna sequences encoding zinc finger binding motifs for display on a viral particle, together with methods of designing zinc finger binding polypeptides for binding to a target sequence |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013448 Pancreas-derived serpin |
| 01/11/2000 | US6013443 Systematic evolution of ligands by exponential enrichment: tissue SELEX |
| 01/11/2000 | US6013432 Testing kit to detect the presence of antibodies to a human immunodeficiency virus in a sample; for diagnosis of human immunodeficiency virus infection or evaluating stage of infection; for vaccine development |
| 01/11/2000 | US6013276 Transdermal matrix system |
| 01/11/2000 | US6013268 Methods for enhancement of protective immune responses |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013256 Administering to human patients undergoing renal transplants effective dosage of chimeric or humanized monoclonal antibody that binds to p55 subunit of human interleukin-2 (il-2) receptor and inhibits binding of il-2 to an il-2 receptor |
| 01/11/2000 | US6013253 Administering combination of consensus interferon and interleukin-1 receptor antagonist to reduce weight loss associated with treatmet of multiple sclerosis with using interferon alone |
| 01/11/2000 | US6013252 Administering interleukin-8 or monocyte chemotactic and activating factor in an amount effective to increase implantation of fertilized ovum or to promote maturation of unfertilized ovum |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | US6013067 Methods for increasing hematopoietic cells |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2107118C Isolated osteogenic factor |
| 01/11/2000 | CA2072375C Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing saidvector and manufacturing method of products which is produced from said microorganism |
| 01/11/2000 | CA2035900C Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells |
| 01/10/2000 | CA2277406A1 Production of protein preparations with a reduced aggregate content |
| 01/10/2000 | CA2277374A1 Process for the preparation of a protein solution |
| 01/06/2000 | WO2000000824A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
| 01/06/2000 | WO2000000644A1 Uses of dna-pk |
| 01/06/2000 | WO2000000633A1 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF |
| 01/06/2000 | WO2000000622A2 Human oxidoreductase proteins |
| 01/06/2000 | WO2000000621A1 Adh7 nucleotides |
| 01/06/2000 | WO2000000617A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 01/06/2000 | WO2000000616A2 Marburg virus vaccines |
| 01/06/2000 | WO2000000615A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
| 01/06/2000 | WO2000000608A2 Immune system molecules |
| 01/06/2000 | WO2000000607A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 01/06/2000 | WO2000000604A1 Methods and compositions for modulating spermatogenesis |